Lidocaine Hydrochloride Injection, USP is supplied as follows:
Unit of Sale | Concentration |
---|---|
NDC 0409-4278-01 Tray of 25 Glass Single-dose Teartop Vials | 0.5% 250 mg/50 mL (5 mg/mL) |
NDC 0409-4713-62 Case of 800 Glass Single-dose Ampuls | 1% 20 mg/2 mL (10 mg/mL) |
NDC 0409-4713-65 Case of 800 Glass Single-dose Ampuls | 1% 50 mg/5 mL (10 mg/mL) |
NDC 0409-4279-02 Tray of 25 Glass Single-dose Teartop Vials | 1% 300 mg/30 mL (10 mg/mL) |
NDC 0409-4776-01 Carton of 25 Glass Single-dose Ampuls | 1.5% 300 mg/20 mL (15 mg/mL) |
NDC 0409-4282-02 Carton of 25 Glass Single-dose Ampuls | 2% 200 mg/10 mL (20 mg/mL) |
Unit of Sale | Concentration |
---|---|
NDC 0409-4713-02 Bundle of 5 Clamcells containing 5 Single-dose Ampuls per Clamcell | 1% 50 mg/5 mL (10 mg/mL) |
NDC 0409-4713-32 Bundle of 5 Cartons containing 10 Single-dose Ampuls per Carton | 1% 20 mg/2 mL (10 mg/mL) |
NDC 0409-4282-01 Bundle of 5 Clamcells containing 5 Single-dose Ampuls per Clamcell | 2% 40 mg/2 mL (20 mg/mL) |
Unit of Sale | Concentration |
---|---|
NDC 0409-4275-01 Tray of 25 Plastic Multiple-dose Fliptop Vials | 0.5% 250 mg/50 mL (5 mg/mL) |
NDC 0409-4276-01 Tray of 25 Plastic Multiple-dose Fliptop Vials | 1% 200 mg/20 mL (10 mg/mL) |
NDC 0409-4276-02 Tray of 25 Plastic Multiple-dose Fliptop Vials | 1% 500 mg/50 mL (10 mg/mL) |
NDC 0409-4277-01 Tray of 25 Plastic Multiple-dose Fliptop Vials | 2% 400 mg/20 mL (20 mg/mL) |
NDC 0409-4277-02 Tray of 25 Plastic Multiple-dose Fliptop Vials | 2% 1000 mg/50 mL (20 mg/mL) |
For single-dose vials and ampuls: Discard unused portion.
Single-dose products are preservative-free.
Store at 20 to 25°C (68 to 77°F). [see USP Controlled Room Temperature.]
Lidocaine Hydrochloride Injection, USP solutions packaged in ampuls and glass teartop vials may be autoclaved one time only. Autoclave at 15 pounds pressure, 121°C (250°F) for 15 minutes. DO NOT AUTOCLAVE PRODUCT IN PLASTIC VIALS.
Lidocaine Hydrochloride Injection, USP is supplied as follows:
Unit of Sale | Concentration |
---|---|
NDC 0409-4278-01 Tray of 25 Glass Single-dose Teartop Vials | 0.5% 250 mg/50 mL (5 mg/mL) |
NDC 0409-4713-62 Case of 800 Glass Single-dose Ampuls | 1% 20 mg/2 mL (10 mg/mL) |
NDC 0409-4713-65 Case of 800 Glass Single-dose Ampuls | 1% 50 mg/5 mL (10 mg/mL) |
NDC 0409-4279-02 Tray of 25 Glass Single-dose Teartop Vials | 1% 300 mg/30 mL (10 mg/mL) |
NDC 0409-4776-01 Carton of 25 Glass Single-dose Ampuls | 1.5% 300 mg/20 mL (15 mg/mL) |
NDC 0409-4282-02 Carton of 25 Glass Single-dose Ampuls | 2% 200 mg/10 mL (20 mg/mL) |
Unit of Sale | Concentration |
---|---|
NDC 0409-4713-02 Bundle of 5 Clamcells containing 5 Single-dose Ampuls per Clamcell | 1% 50 mg/5 mL (10 mg/mL) |
NDC 0409-4713-32 Bundle of 5 Cartons containing 10 Single-dose Ampuls per Carton | 1% 20 mg/2 mL (10 mg/mL) |
NDC 0409-4282-01 Bundle of 5 Clamcells containing 5 Single-dose Ampuls per Clamcell | 2% 40 mg/2 mL (20 mg/mL) |
Unit of Sale | Concentration |
---|---|
NDC 0409-4275-01 Tray of 25 Plastic Multiple-dose Fliptop Vials | 0.5% 250 mg/50 mL (5 mg/mL) |
NDC 0409-4276-01 Tray of 25 Plastic Multiple-dose Fliptop Vials | 1% 200 mg/20 mL (10 mg/mL) |
NDC 0409-4276-02 Tray of 25 Plastic Multiple-dose Fliptop Vials | 1% 500 mg/50 mL (10 mg/mL) |
NDC 0409-4277-01 Tray of 25 Plastic Multiple-dose Fliptop Vials | 2% 400 mg/20 mL (20 mg/mL) |
NDC 0409-4277-02 Tray of 25 Plastic Multiple-dose Fliptop Vials | 2% 1000 mg/50 mL (20 mg/mL) |
For single-dose vials and ampuls: Discard unused portion.
Single-dose products are preservative-free.
Store at 20 to 25°C (68 to 77°F). [see USP Controlled Room Temperature.]
Lidocaine Hydrochloride Injection, USP solutions packaged in ampuls and glass teartop vials may be autoclaved one time only. Autoclave at 15 pounds pressure, 121°C (250°F) for 15 minutes. DO NOT AUTOCLAVE PRODUCT IN PLASTIC VIALS.
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.